Sponsor content
59 result(s) found, displaying 1 to 10
-
Cancellation or suspensionThe medicine is not eligible for listing (paragraph 30(1A)(a) of the Act).
It appears to the Secretary that the presentation of the goods is unacceptable (paragraph 30(2)(aa) of the Act).
The goods do not conform to a standard applicable to the goods (paragraph 30(2)(e) of the Act). -
Listed medicine compliance reportMedicine is no longer permitted to be supplied (View full entry for advice on the safety of using this medicine.)
-
Cancellation by sponsorRequested by Australia Biotechnology Group Pty Ltd
-
Cancellation by sponsorRequested by Australia Biotechnology Group Pty Ltd
-
Cancellation for failure to pay annual chargeCancelled under Section 30(1)(h) of the Act
-
Cancellation for failure to pay annual chargeCancelled under Section 30(1)(h) of the Act
-
Listed medicine compliance reportMedicine continues to be permitted for supply (View full entry for advice on the safety of using this medicine.)
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NMN 23000+ Boost.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NAD+ III Boost.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABC NAD+ Booster III.